Scheer Partners Completes 102,000-Square-foot GMP facility on behalf of
Mediatech, Inc.
For Immediate Release: October 22, 2007
PR Contact:
Mike Norris
Scheer Partners Inc.
(301) 770-1430
mnorris@scheerpartners.com
Scheer Partners, a leading provider of real estate services to life sciences companies, is pleased to announce its completion of a 102,000-square-foot GMP (Good Manufacturing Processes) facility on behalf of Mediatech, Inc., a leading manufacturer and supplier of cell culture and molecular biology reagents to biopharmaceutical, academic and government research facilities, as well as biotechnology companies.
The facility is situated on 10 acres at Innovation Technology Park, a 1,500-acre site owned by Prince William County for the purposes of attracting targeted industries, including life sciences. The development adds to an already flourishing market including the American Type Culture Center and George Mason University, whose recent completion of its 80,000-square-foot biocontainment facility and proposed expansion of the Mason Enterprise Center incubator should prove to be a catalyst for the life sciences industry in Northern Virginia.
The biotech cluster that’s emerging along the I-66 corridor is not the only attraction to Manassas. “The relative low cost and availability of land coupled with the favorable business climate of the Commonwealth of Virginia has made Prince William County an attractive location for companies needing technical facilities,” said Mike Norris, director at Scheer Partners and board member of the Business Alliance of George Mason University. Scheer Partners is also managing the construction of the Virginia Department of Forensic Sciences’ 100,000-square-foot facility, which is projected to result in a $63 million total investment.
About Mediatech, Inc
Mediatech, Inc. is a leading manufacturer and supplier of cell culture and molecular biology reagents to biopharmaceutical, academic and government research facilities, as well as biotechnology companies. In addition to following current Good Manufacturing Processes (cGMP) and complying with FDA Guidelines for Class I Medical Devices, Mediatech is certified under ISO 13485:2003 and compliant with ISO 17025:2001. Mediatech's facility design and Quality Assurance Systems guarantee low endotoxin levels for both liquid and powdered products and meets the most rigid Sterility Assurance Levels for liquid products. All cellgro(R) basal media and salt solutions must test negative for mycoplasma prior to release. For more information visit http://www.cellgro.com